Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest
about
p53-dependent ceramide response to genotoxic stressRoles of bioactive sphingolipids in cancer biology and therapeuticsA house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell deathCeramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocationCell cycle arrest of hematopoietic cell lines after treatment with ceramide is commonly associated with retinoblastoma activation.Modulation of ceramide content and lack of apoptosis in the chronically hypoxic neonatal rat heart.Apoptosis and the activity of ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia.The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis.2'-hydroxy C16-ceramide induces apoptosis-associated proteomic changes in C6 glioma cells.Age-dependent changes in the sphingolipid composition of mouse CD4+ T cell membranes and immune synapses implicate glucosylceramides in age-related T cell dysfunctionCancer treatment strategies targeting sphingolipid metabolism.The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell deathAutophagy in the light of sphingolipid metabolismInvolvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells.Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathwaySphingolipids in cancer: regulation of pathogenesis and therapy.Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death.Asymmetric dimethylarginine attenuates serum starvation-induced apoptosis via suppression of the Fas (APO-1/CD95)/JNK (SAPK) pathway.Bcl-2 interrupts the ceramide-mediated pathway of cell death.Therapeutic applications of bioactive sphingolipids in hematological malignancies.Ceramide function in the brain: when a slight tilt is enough.p53 and Ceramide as Collaborators in the Stress ResponseSphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistanceSphingolipids in the DNA damage response.Sphingosine-1-phosphate metabolism: A structural perspective.Sphingolipids in mitochondria.Sphingolipid metabolism is a crucial determinant of cellular fate in nonstimulated proliferating Madin-Darby canine kidney (MDCK) cells.Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells.Ceramide-induced G2 arrest in rhabdomyosarcoma (RMS) cells requires p21Cip1/Waf1 induction and is prevented by MDM2 overexpression.Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl)retinamideEfficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action.Decreased activity and enhanced nuclear export of CCAAT-enhancer-binding protein beta during inhibition of adipogenesis by ceramide.Ceramide inhibits PKCθ by regulating its phosphorylation and translocation to lipid rafts in Jurkat cells.Production of ceramides causes apoptosis during early neural differentiation in vitro.Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.Aryl hydrocarbon receptor regulation of ceramide-induced apoptosis in murine hepatoma 1c1c7 cells. A function independent of aryl hydrocarbon receptor nuclear translocator.Role of ceramide in lipopolysaccharide (LPS)-induced signaling. LPS increases ceramide rather than acting as a structural homolog.Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M.Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein.
P2860
Q24564604-C8D9B41B-F163-4C4B-B254-343297EEDDA8Q24657499-8D4DA412-7028-4A73-9621-E2375518F9D0Q24675372-31BF3D02-6911-4E88-9DFB-F612EDBAF897Q28348363-FDBFDAFB-590D-4BAF-AD8D-AED8FBE6A96CQ31912759-D1BDA67B-544D-4C24-BE98-C40DE1375416Q33183309-7DFDC0A4-C246-4D36-AD32-14BA2D6E6486Q33251853-66CB799B-DDF5-42CE-B786-458EF624D9BAQ33782414-ACEFC692-9EDC-4DBE-BDC3-1FBC4127F11CQ34008607-F7BDA90C-1E2B-4E60-BCFF-B8B63A72F398Q34460494-8CB3F727-86EE-4559-A378-C51CEAEC8B06Q34790629-46A6729C-F22B-4D60-BEE5-71E5FE6233ABQ34914286-C8B6F720-E48B-4000-86CA-CE57D1916EE6Q35225431-AED82B4A-5C2F-459C-8088-D7A5463AB8B3Q36157119-5C1A1AB7-68D9-47BD-B57D-4B9A8F344598Q36376514-81C0589A-2558-447A-8FE9-C56F7978C8F0Q36592826-D7B20FA9-0F3E-48C7-99F1-A5C6CB7910B5Q37140394-2AA887D8-AEF7-43A7-8821-084A6EE4CAF1Q37299599-45DEE0D9-73BE-4AFA-904F-1E10467F9CDBQ37583838-F73455AD-162F-43DD-A15D-7C0C532B378EQ37760875-3E0F35E1-5773-4AFE-9F01-C167C5556BE0Q38021345-1BDFA50B-D7E6-465D-9E7B-0AD5F99ABA55Q38086020-13914478-F07F-4A74-AE18-DFDA817589E9Q38195691-48637443-C606-4B89-8D38-66C50BDCFBE8Q38272799-3328F326-F6FC-40C7-AE3E-ADE829095E5AQ38448843-A9B6A699-EEE7-4716-91E2-49B62BB66D5AQ38809404-8879A65B-DCEE-4A61-99AA-63FDDB3F7E43Q39961635-DCA2A1CB-CFB1-47F0-AB25-5C64A40DE8CDQ40022032-AE453D2A-2719-4404-AA8C-B4EB3E6A0DBEQ40107851-A696AC12-3C94-4B40-AB64-B8697B4B51CFQ40387380-0E5D014C-CF1B-4C4B-8E73-49EF7C778C16Q40492153-4F67E297-5A9E-4C7D-BBAA-FF7E0BB99B5AQ40513977-89C9FF5F-57AA-42E3-AE93-070B68821E8FQ40724084-325D1EA2-D48E-485F-96C0-8CD3B64A29DAQ40822072-0F768497-B93A-48EE-A5C4-5ABFE2382416Q40872435-956A5E30-4549-4958-AEE6-C11C4E78AB45Q40889956-48F324F4-50B1-44DB-80E3-AFFC8D104C0AQ40980110-C3211099-3064-4861-89EB-DBFDDC010C7CQ40982585-14CD5F37-7976-4A27-B68F-1F1600E52B53Q41013768-71BE9FE7-12C4-4185-A219-0A19068EFED0Q41083675-21CE3C9A-036E-465A-B63E-5FF930A0E574
P2860
Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Retinoblastoma gene product as ...... ndent pathway of growth arrest
@ast
Retinoblastoma gene product as ...... ndent pathway of growth arrest
@en
Retinoblastoma gene product as ...... ndent pathway of growth arrest
@nl
type
label
Retinoblastoma gene product as ...... ndent pathway of growth arrest
@ast
Retinoblastoma gene product as ...... ndent pathway of growth arrest
@en
Retinoblastoma gene product as ...... ndent pathway of growth arrest
@nl
prefLabel
Retinoblastoma gene product as ...... ndent pathway of growth arrest
@ast
Retinoblastoma gene product as ...... ndent pathway of growth arrest
@en
Retinoblastoma gene product as ...... ndent pathway of growth arrest
@nl
P2093
P2860
P356
P1476
Retinoblastoma gene product as ...... ndent pathway of growth arrest
@en
P2093
G S Dbaibo
J K Schwarz
J M Horowitz
M Y Pushkareva
Y A Hannun
P2860
P304
P356
10.1073/PNAS.92.5.1347
P407
P577
1995-02-28T00:00:00Z